InvestorsHub Logo
Followers 27
Posts 2112
Boards Moderated 0
Alias Born 09/12/2012

Re: newman2021 post# 639619

Wednesday, 10/11/2023 5:42:49 PM

Wednesday, October 11, 2023 5:42:49 PM

Post# of 688664
you're absolutely right, no doubt about it . . . and . . . . much, much better our DCVax, our NWBO.

let that sink in:
THEY have phase 2- study, a combi therapie with Roches Avastiin.
and "just"
- clinical superiority as a first-line treatment for unresectable or metastatic hepatocellular carcinoma, a common type of liver cancer
- Patients treated with the triple therapy had median progression-free survival of seven months, versus 4.3 months for those treated only with Tecentriq and Avastin,

DCvax-L alone ! ! ALONE has better results
DCvax-L combi thretment has over 60% survival!
- for the deadliest cancer GBM !
- therapie/cure for most, if not ALL solid cancers
- maybe therapie for viruses / nearly all illnesses

+
DCvax-D

So, there are two questions - lets discuss

1.

- how much will we rise, even with higher number of outstanding shares?

on a single day?
on just a single day, or for days?
for weeks?
for months?
for years?
for decades?

2.

how is it (well, we know but . . . . ) HOW ISSSS ITTTT, that we went after PHASE3 outstanding data from 2,50 to 40 cents ? ?

HOW IS THAT ? ?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News